Publications by authors named "B Barlogie"

Claim this Profile
A
Altered mesenchymal and endothelial subsets in interstitial bone marrow and focal lesions in myeloma patients and SCID-hu mice.
Wen Ling, Maurizio Zangari, Frits Van Rhee, Bart Barlogie, Shmuel Yaccoby

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of focal lesion location and persistence in multiple myeloma: insights from serial PET/DWI imaging.
Carolina Schinke, Leo Rasche, Cody Ashby, Rudy van Hemert, Sharmilan Thanendrarajan, Bart Barlogie

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols: A Secondary Analysis of 3 Clinical Trials.
Samer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, Sharmilan Thanendrarajan, Eric R Siegel, Bart Barlogie

JAMA Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of HMOX1 by mesenchymal stem cell cytotherapy inhibits osteoclastogenesis and myeloma-induced bone disease.
Xin Li, Wen Ling, Bart Barlogie, Shmuel Yaccoby

Clin Transl Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma.
Samer Al Hadidi, Obada Ababneh, Carolina Schinke, Sharmilan Thanendrarajan, Clyde Bailey, Bart Barlogie

Blood Adv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis